Arbutus Biopharma ABUS
NASDAQ ABUS
$3.81 -0.01 (-0.39%)
As of: Nov 11, 2026 · 11:53 AM EST

Arbutus Biopharma (ABUS) Return on Capital Employed [ROCE] (2010 - 2026)

Updated

Arbutus Biopharma (ABUS) reported Return on Capital Employed [ROCE] of 54.73% for Q2 2026, up 111.41 percentage points from -56.68% a year earlier but down 31.81 percentage points from the prior quarter.

Analysis

Arbutus Biopharma (ABUS) Return on Capital Employed [ROCE] (2010 - 2026) Analysis & Trends

For FY2025, Arbutus Biopharma posted Return on Capital Employed [ROCE] of -35.61%, up 26.72 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has a five-year change of +16.11 percentage points (FY2020 to FY2025).
  • By year, Return on Capital Employed [ROCE] came in at -62.33% in FY2024 (-9.35 pp), -52.98% in FY2023 (-13.81 pp), -39.17% in FY2022 (+6.90 pp) and -46.08% in FY2021 (+5.64 pp).
  • Five-year quarterly Return on Capital Employed [ROCE] spans a low of -78.77% in Q1 2025 and a high of 86.54% in Q1 2026.
  • Year over year, Return on Capital Employed [ROCE] has now increased in each of the last five quarters, with an average year-over-year change of +36.39 percentage points over the last eight quarters.
  • The high point for year-over-year Return on Capital Employed [ROCE] in five years was Q1 2026 (a gain of 165.31 percentage points); the low point was Q4 2023 (a drop of 21.28 percentage points).
  • Per Business Quant data, the three quarters before Q2 2026 came in at 86.54% (Q1 2026), -42.33% (Q4 2025) and -49.11% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Arbutus Biopharma 758.95 Mn 142.14 Mn - 226.65%
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 226.65%
Jun 30, 2026 54.73%
Mar 31, 2026 86.54%
Dec 31, 2025 -42.33%
Sep 30, 2025 -49.11%
Jun 30, 2025 -56.68%
Mar 31, 2025 -78.77%
Dec 31, 2024 -63.36%
Sep 30, 2024 -63.31%
Jun 30, 2024 -62.80%
Mar 31, 2024 -63.01%
Dec 31, 2023 -60.53%
Sep 30, 2023 -54.96%
Jun 30, 2023 -47.76%
Mar 31, 2023 -42.75%
Dec 31, 2022 -39.25%
Sep 30, 2022 -34.93%
Jun 30, 2022 -32.71%
Mar 31, 2022 -36.55%
Dec 31, 2021 -42.30%
API Access

Arbutus Biopharma Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=ABUS&period=max&api_key=YOUR_API_KEY